» Articles » PMID: 15509788

Neuroprotective Role of the Reaper-related Serine Protease HtrA2/Omi Revealed by Targeted Deletion in Mice

Abstract

The serine protease HtrA2/Omi is released from the mitochondrial intermembrane space following apoptotic stimuli. Once in the cytosol, HtrA2/Omi has been implicated in promoting cell death by binding to inhibitor of apoptosis proteins (IAPs) via its amino-terminal Reaper-related motif, thus inducing caspase activity, and also in mediating caspase-independent death through its own protease activity. We report here the phenotype of mice entirely lacking expression of HtrA2/Omi due to targeted deletion of its gene, Prss25. These animals, or cells derived from them, show no evidence of reduced rates of cell death but on the contrary suffer loss of a population of neurons in the striatum, resulting in a neurodegenerative disorder with a parkinsonian phenotype that leads to death of the mice around 30 days after birth. The phenotype of these mice suggests that it is the protease function of this protein and not its IAP binding motif that is critical. This conclusion is reinforced by the finding that simultaneous deletion of the other major IAP binding protein, Smac/DIABLO, does not obviously alter the phenotype of HtrA2/Omi knockout mice or cells derived from them. Mammalian HtrA2/Omi is therefore likely to function in vivo in a manner similar to that of its bacterial homologues DegS and DegP, which are involved in protection against cell stress, and not like the proapoptotic Reaper family proteins in Drosophila melanogaster.

Citing Articles

Selective diagnostics of Amyotrophic Lateral Sclerosis, Alzheimer's and Parkinson's Diseases with machine learning and miRNA.

Lee J, Kouznetsova V, Kesari S, Tsigelny I Metab Brain Dis. 2025; 40(1):79.

PMID: 39747792 DOI: 10.1007/s11011-024-01490-w.


Structural basis of substrate recognition and allosteric activation of the proapoptotic mitochondrial HtrA2 protease.

Aspholm E, Lidman J, Burmann B Nat Commun. 2024; 15(1):4592.

PMID: 38816423 PMC: 11535027. DOI: 10.1038/s41467-024-48997-5.


HTRA2/OMI-Mediated Mitochondrial Quality Control Alters Macrophage Polarization Affecting Systemic Chronic Inflammation.

Liu Q, Yan X, Yuan Y, Li R, Zhao Y, Fu J Int J Mol Sci. 2024; 25(3).

PMID: 38338855 PMC: 10855076. DOI: 10.3390/ijms25031577.


CLPB disaggregase dysfunction impacts the functional integrity of the proteolytic SPY complex.

Baker M, Blau K, Anderson A, Palmer C, Fielden L, Crameri J J Cell Biol. 2024; 223(3).

PMID: 38270563 PMC: 10818064. DOI: 10.1083/jcb.202305087.


A sporadic Parkinson's disease model via silencing of the ubiquitin-proteasome/E3 ligase component, SKP1A.

Fishman-Jacob T, Youdim M J Neural Transm (Vienna). 2023; 131(6):675-707.

PMID: 37644186 PMC: 11192832. DOI: 10.1007/s00702-023-02687-6.


References
1.
van Gurp M, Festjens N, van Loo G, Saelens X, Vandenabeele P . Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun. 2003; 304(3):487-97. DOI: 10.1016/s0006-291x(03)00621-1. View

2.
Srinivasula S, Gupta S, Datta P, Zhang Z, Hegde R, Cheong N . Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2. J Biol Chem. 2003; 278(34):31469-72. DOI: 10.1074/jbc.C300240200. View

3.
Hell K, Saleh M, Crescenzo G, OConnor-McCourt M, Nicholson D . Substrate cleavage by caspases generates protein fragments with Smac/Diablo-like activities. Cell Death Differ. 2003; 10(11):1234-9. DOI: 10.1038/sj.cdd.4401298. View

4.
Hegde R, Srinivasula S, Datta P, Madesh M, Wassell R, Zhang Z . The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein. J Biol Chem. 2003; 278(40):38699-706. DOI: 10.1074/jbc.M303179200. View

5.
Hegde R, Srinivasula S, Zhang Z, Wassell R, Mukattash R, Cilenti L . Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem. 2001; 277(1):432-8. DOI: 10.1074/jbc.M109721200. View